Skip to main content
VCbacked
Log inGet Started

Amani Therapeutics

New York, United States

Amani uses cutting-edge research to break down barriers and provide people with severe mental illness with efficient treatments.

$25.0M raised
Mar 2026
Series A

Top Investors

RTW Investments

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amani Therapeutics

How much funding has Amani Therapeutics raised?
Amani Therapeutics has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.
Who are Amani Therapeutics's investors?
Amani Therapeutics's investors include RTW Investments.
Where is Amani Therapeutics headquartered?
Amani Therapeutics is headquartered in New York, United States.
What does Amani Therapeutics do?
Amani uses cutting-edge research to break down barriers and provide people with severe mental illness with efficient treatments.
What stage is Amani Therapeutics at?
Amani Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Amani Therapeutics — Funding & Investors." VCBacked, March 23, 2026, https://www.vcbacked.co/company/amani-therapeutics. Accessed July 4, 2026.
APA
VCBacked. (2026). Amani Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/amani-therapeutics
Wikipedia (cite web)
{{cite web |title=Amani Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amani-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .